BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1469 related articles for article (PubMed ID: 23423883)

  • 1. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.
    Jégu J; Binder-Foucard F; Borel C; Velten M
    Oral Oncol; 2013 Jan; 49(1):9-14. PubMed ID: 22840787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer.
    Morris LG; Sikora AG; Patel SG; Hayes RB; Ganly I
    J Clin Oncol; 2011 Feb; 29(6):739-46. PubMed ID: 21189382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
    Forte T; Niu J; Lockwood GA; Bryant HE
    Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Risk of Second Primary Malignant Neoplasm After a First Head and Neck Squamous Cell Carcinoma.
    Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Schootman M; Piccirillo JF
    JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):727-737. PubMed ID: 30027284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
    Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
    J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.
    Diaz DA; Reis IM; Weed DT; Elsayyad N; Samuels M; Abramowitz MC
    Head Neck; 2016 Apr; 38 Suppl 1():E873-83. PubMed ID: 25966421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
    Huang SH; Perez-Ordonez B; Liu FF; Waldron J; Ringash J; Irish J; Cummings B; Siu LL; Kim J; Weinreb I; Hope A; Gullane P; Brown D; Shi W; O'Sullivan B
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):276-83. PubMed ID: 20950953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and genotype distribution of multiple human papillomavirus infections in cancer of the head and neck in a Mexican population.
    Ibieta-Zarco BR; Carrillo-García A; Ponce-de-León-Rosales S; Flores-Miranda MM; Mohar A; Lizano M
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Sep; 114(3):350-7. PubMed ID: 22862976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metachronous Second Primary Malignancies after Head and Neck Cancer in a Korean Cohort (1993-2010).
    Jung YS; Lim J; Jung KW; Ryu J; Won YJ
    PLoS One; 2015; 10(7):e0134160. PubMed ID: 26218068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Nelson RA; Lai LL
    Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus and head and neck cancer: a growing concern.
    Gillespie MB; Smith J; Gibbs K; McRackan T; Rubinchik S; Day TA; Sutkowski N
    J S C Med Assoc; 2008 Dec; 104(8):247-51. PubMed ID: 19326612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer.
    Wang WL; Wang YC; Chang CY; Lo JL; Kuo YH; Hwang TZ; Wang CC; Mo LR; Lin JT; Lee CT
    Laryngoscope; 2016 May; 126(5):1097-102. PubMed ID: 27107411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human papilloma virus in head and neck cancer].
    Barry B; Ortholan C
    Cancer Radiother; 2014 Oct; 18(5-6):430-3. PubMed ID: 25151649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second primary head and neck tumor risk in patients with cervical cancer--SEER data analysis.
    Rose Ragin CC; Taioli E
    Head Neck; 2008 Jan; 30(1):58-66. PubMed ID: 17657793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low prevalence of human papillomavirus in oral cavity carcinomas.
    Machado J; Reis PP; Zhang T; Simpson C; Xu W; Perez-Ordonez B; Goldstein DP; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Kamel-Reid S
    Head Neck Oncol; 2010 Mar; 2():6. PubMed ID: 20226055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.
    Ang KK; Sturgis EM
    Semin Radiat Oncol; 2012 Apr; 22(2):128-42. PubMed ID: 22385920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.
    Jelihovschi I; Bidescu AC; Tucaliuc SE; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):502-9. PubMed ID: 26204659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of human papillomavirus-related head and neck cancer.
    Joseph AW; D'Souza G
    Otolaryngol Clin North Am; 2012 Aug; 45(4):739-64. PubMed ID: 22793850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.